(Q40058815)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Gemma Leon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Padraic G. Fallon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Fergus Shanahan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Elizabeth K Brint

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Silvia Melgar

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Séamus Hussey

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Patrick T Walsh

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

S E Russell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

R M Horan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

A M Stefanska

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

A Carey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

M Aguilera

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

D Statovci

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

T Moran

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

1 reference

27 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

1193-1204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26813344%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/mi.2015.134

6 March 2020

exact match

0 references

cites work

Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Cytokine and anti-cytokine therapies for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Targeting TNF-α for the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

New drug therapies on the horizon for IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Genetics and pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Rapid rise in incidence of Irish paediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Biology of IL-36 cytokines and their role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

The interleukin-1 family: back to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

IL-36R ligands are potent regulators of dendritic and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Interleukin-1 family member 9 stimulates chemokine production and neutrophil influx in mouse lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

IL-36α exerts pro-inflammatory effects in the lungs of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

The IL-36 receptor pathway regulates Aspergillus fumigatus-induced Th1 and Th17 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Cytokines in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Two physically, functionally, and developmentally distinct peritoneal macrophage subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Natural killer cells protect against mucosal and systemic infection with the enteric pathogen Citrobacter rodentium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Citrobacter rodentium: infection, inflammation and the microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Soluble IL-2Rα (sCD25) exacerbates autoimmunity and enhances the development of Th17 responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

TH9 cells that express the transcription factor PU.1 drive T cell–mediated colitis via IL-9 receptor signaling in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2015.134

Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease

21 January 2018

1 reference

12 December 2020

IL-36 a new member of the IL-1 family cytokines

1 reference

12 December 2020

Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism

1 reference

12 December 2020

The rising incidence of paediatric-onset inflammatory bowel disease

1 reference

12 December 2020

Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution

1 reference

12 December 2020